Abstract: Compositions and methods for the prevention and treatment of stress-induced fear, depressive-like and anxiety-like behavior using selective VPAC2 agonist Bay 55-9837.

Abstract: F estimating an anomaly in an environment a dimensionally accurate three-dimensional model associated with the environment is obtained from a memory, providing a three-dimensional position of objects in the environment. Thermal sensor data originating from a thermal sensor and image sensor data originating from an image sensor arranged in the environment is obtained. The thermal sensor data and image sensor data includes real-time image data associated with the environment, the thermal sensor and image sensor having known locations in the dimensionally accurate three-dimensional model. Locations of image pixels in the thermal sensor data, the image sensor data and a point of view of a camera associated with the dimensionally accurate three-dimensional model are mapped, and one of a location and size of an anomaly indicated by the thermal sensor data is estimated, the anomaly being associated with an object in the dimensionally accurate three-dimensional model based on the mapping.

Abstract: A method and apparatus for classifying a text using a text classification model are disclosed. In one general aspect, an apparatus is for outputting a classification result for an input text including words by using a text classification model, and the apparatus includes: one or more processors; a memory including instructions configured to cause the one or more processors to: determine whether the input text indicates an anomaly; and responsive to determining that the input text indicates an anomaly: determine saliencies of the respective words; select target words from among the words based on the saliencies; generate a replaced text by replacing, in the input text, the selected words with other words; and obtain a text classification result of the input text based on an inference upon the replaced text by the text classification model receiving the replaced text as an input.

Abstract: In a method and device for reverse transmission of rapid data in a communication system, an AP method includes the steps of: setting up a service section with a STA; transmitting, to the STA, a first data frame containing information indicating that reverse communication is allowed in the service section; receiving, from the STA, a first reception response frame with respect to the first data frame; and performing reverse communication with the STA in a remaining section within the service section.

Abstract: A virtual negative edge-based directed network embedding method and system are disclosed. A network embedding method performed by a network embedding system according to an embodiment may comprise the steps of: searching for a virtual negative edge representing a potentially negative relationship between nodes within a directed network; and performing network embedding for expressing the nodes within the directed network as low-dimensional vectors by using the searched virtual negative edge.

Abstract: Disclosed are a nerve stimulator electrode and a method of manufacturing the same. More particularly, the present invention provides a nerve stimulator electrode including biocompatible solid electrolyte; and an ion diffusion barrier formed on the biocompatible solid electrolyte, wherein the biocompatible solid electrolyte includes an ionic liquid and a biocompatible polymer matrix.

Abstract: A method and a device are disclosed for a non-simultaneous transmit and receive (NSTR) operation in a communication system supporting multiple links. An operating method of a device comprises the steps of: receiving, from an AP, a first frame including configuration information about a TWT SP in a first link from among multiple links; transmitting, to an STA, a second frame including configuration information about a QTP overlapping with the TWT SP in a second link from among the multiple links; and communicating with the AP within the TWT SP configured in the first link.

Abstract: The present invention relates to a punching-type iridotomy instrument, and more particularly, to a punching-type iridotomy instrument which, in iridectomy, increases the size and positioning accuracy iris incision through structural improvement in a perforation method, thereby shortening the surgery time and facilitating the convenience of surgical procedures.

Abstract: An apparatus and method with out-of-distribution data detection is provided. The apparatus includes one or more processors configured to execute instructions; and one or more memories storing the instructions, wherein, the execution of the instructions by the one or more processors configures the one or more processors to generate output data using a neural network model provided input data; determine, based on the output data, a maximum loss value among calculated loss values that correspond to neighboring data within a reference distance from the input data; and detect, based on the maximum loss value and a threshold, whether the input data is out-of-distribution (OOD) data that is different from in-distribution data corresponding to training data used in a training of the neural network model.

Abstract: An object of the present disclosure is to provide a composition for preventing or treating obesity comprising a substance isolated from poly-?-glutamic acid (?-PGA) as an active ingredient. According to the present disclosure, it was confirmed that ?-PGAbm or ?-PGAcm, a substance isolated from ?-PGA, suppressed the expression of adipogenic marker genes in 3T3-L1 cells to reduce accumulation of lipid droplets and triglycerides, and suppressed the expression of cell cycle regulators in the early stage of adipogenesis to reduce adipocyte differentiation. In addition, ?-PGAbm or ?-PGAcm has been confirmed to suppress obesity through weight loss, positive changes in glucose and insulin resistance, reduction of epididymal adipocytes, and suppression of adipogenesis, and thus may be used effectively for related businesses.

Abstract: The present invention relates to a degradable substrate for an electronic device, a degradable substrate assembly for an electronic device, and a method for manufacturing a degradable substrate for an electronic device. The degradable substrate for an electronic device according to an embodiment of the present invention comprises: a substrate base material which is a polymer material; and a degradable foam-generating material which is in the form of particles uniformly mixed with the substrate base material and generates foam by reacting with water.

Abstract: An object of the present invention is to provide an oral administration agent for a pregnant woman for used in increasing a blood short-chain fatty acid concentration in a pregnant woman or an unborn baby, imparting resistance to obesity to an unborn baby, or preventing postnatal obesity or a disorder resulting from postnatal obesity of an unborn baby, and, in order to achieve the object, the present invention provides an oral administration agent for a pregnant woman containing an oligosaccharide, for used in increasing a blood short-chain fatty acid concentration in a pregnant woman or an unborn baby, imparting resistance to obesity to an unborn baby, or preventing postnatal obesity or a disorder resulting from postnatal obesity of an unborn baby.

Abstract: The present invention relates to a serverless computing method and apparatus, and more particularly, to a serverless computing method and apparatus using mutual monitoring between network edges. The serverless computing method according to one embodiment of the present invention comprises monitoring, by an event handler of the first network edge, an event occurring in the second network edge, generating, by an event generating module of the second network edge, an event response signal through filtering on the event in response to the event occurring, transmitting, by an event delivery module of the second network edge, the event response signal to the event handler of the first network edge, and scaling an application, by an auto-scaler, in the first network edge based on the event response signal.

Abstract: There is provided a deep learning model training method using a self-knowledge distillation algorithm. The method comprises inputting training data to a deep learning model at a first time to obtain first output vectors and inputting the training data to the deep learning model at a second time before the first time to obtain second output vectors; generating soft target vectors at the first time point with respect to the training data using the second output vectors and label data; sorting the first output vectors and the soft target vectors and generating a first partial distribution for the sorted first output vectors and a second partial distribution for the sorted soft target vectors; and training the deep learning model to minimize a first loss function determined on the basis of the first partial distribution and the second partial distribution.

Abstract: A snap-through joint module is provided. The snap-through joint module includes a first member having a first internal space to which pneumatic pressure is applied, a second member having a second internal space to which pneumatic pressure is applied, a snap joint portion configured to connect the first member to the second member and capable of a snap-through movement by pneumatic pressure applied to the first member and the second member, and a controller configured to control pneumatic pressure applied to the first internal space and the second internal space.

Abstract: The present invention relates to a method for prevention, alleviation, or treatment of cancer patients, especially epithelial mesenchymal transition (EMP)-subtype cancer patients. If PHGDH, SHMT and MTHFD2 inhibitors are co-administered to patients with cancer in which the expression level of a glutaminase (GLS) gene or a protein encoded thereby has increased, 1C metabolism is more effectively inhibited such that there is a synergistic effect on the inhibition of cancer cell proliferation in patients with refractory cancer that is difficult to treat because of recurrence, metastasis, and anticancer drug resistance, thereby enabling cancer to be very effectively treated. In addition, the expression level of the GLS gene or protein encoded thereby is measured so that information related to customized treatment methods from initial stages is provided to each patient and the success of treatment can be increased.

Abstract: Disclosed are a method and device for transmitting synchronization information for a NSTR operation in a communication system supporting multi-links. A method of an AP MLD includes the steps of: transmitting a first trigger frame over a first link; transmitting a second trigger frame over a second link; receiving, over the first link, a first data frame triggered by the first trigger frame; receiving, over the second link, a second data frame triggered by the second trigger frame; generating a first reception response frame and a second reception response frame having the same lengths; transmitting the first reception response frame over the first link, as a response to the first data frame; and transmitting the second reception response frame over the second link, as a response to the second data frame.

Abstract: This document provides methods and materials for improving arteriovenous fistula (AVF) maturation and/or maintaining AVF functionality. For example, methods and materials for using one or more senolytic agents to improve AVF maturation, to maintain AVF functionality, and/or to maintain the patency of an AVF are provided. Methods and materials for using one or more senolytic agents to maintain functionality and/or patency of a venous graft (e.g., a venous graft that bypasses an occluded artery) also are provided.

Abstract: The disclosed apparatus, systems and methods relate to devices, systems and methods for improving thrombolysis via synergetic application of thrombolytics with physical factors, such as in acute ischemic stroke patients. Vibration in the low (0.5-120 Hz) frequency range is synergistic with tissue plasminogen activators (rtPA), significantly improving the effectiveness of thrombolysis without impairing blood brain barrier permeability. Administration of low frequency vibration combined with rtPA improve acute ischemic stroke outcomes.

Abstract: A function of cyclin-dependent kinase 12 (CDK12) as a biomarker for a human epidermal growth factor receptor 2 (HER2)-positive cancer and anti-HER2 therapy, and a use of the CDK12 are provided. The CDK12 may be used for companion diagnostics of a HER2-targeted therapeutic agent for a subject having HER2+ cancer as a prognostic factor and a predictive factor for response of the subject to the anti-HER2-targeted therapeutic agent in HER2+ cancer, or used to check the probability of expressing resistance to the HER2-targeted therapeutic agent. When the CDK12 is amplified or expressed at a level higher than a reference value, the CDK12 may be suppressed to overcome the resistance to the HER2 therapeutic agent and improve a therapeutic effect, thereby improving the therapeutic efficiency of HER2-positive cancer.